Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

1791 - 1800 of 2253 results found

Molnupiravir and risk of post-acute sequelae of covid-19: cohort study

Date
Wednesday, May 10, 2023 - 4:00 AM
Description
CONCLUSIONS: In people with SARS-CoV-2 infection and at least one risk factor for progression to severe covid-19, compared with no treatment, molnupiravir use within five days of infection was associated with reduced risk of PASC in people who had